— Know what they know.
Not Investment Advice

MDCN OTC

Medican Enterprises, Inc.
1W: +0.0% 1M: -99.0% 3M: -99.0% YTD: +0.0% 1Y: +0.0% 3Y: +900.0% 5Y: +900.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±9874.5%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 54 · $2.9M mcap · 28.81B float · 0.0074% daily turnover · Short 5% of daily vol

Balance Sheet Trends

Total Assets
$48M +10.9% ▲
Total Liabilities
$20M -22.1% ▼
5Y CAGR: +131.7%
Shareholders Equity
$28M +57.2% ▲
Cash & Investments
$75K -79.1% ▼
Total Debt
$20M -22.1% ▼
5Y CAGR: +179.3%
Net Debt
$20M -21.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2014FY2019FY2020FY2021FY2022
— Assets —
Cash$80K$15K$25K$360K$75K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$80K$15K$25K$360K$75K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$113K$15K$25K$360K$75K
Property, Plant & Equip.$0$9M$15M$18M$22M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$33M$26M$25M$26M
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$41M$40M$43M$48M
Total Assets$113K$41M$40M$44M$48M
— Liabilities —
Accounts Payable$2M$0$0$0$0
Short-Term Debt$6M$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$146K$0$0$0$0
Total Current Liabilities$8M$0$0$0$0
Long-Term Debt$0$34M$28M$25M$20M
Other Non-Current Liab.$389K$0$0$0$0
Total Non-Current Liabilities$389K$34M$28M$25M$20M
Total Liabilities$8M$34M$28M$25M$20M
— Equity —
Common Stock$49K$10M$10M$39M$39M
Retained Earnings-$58M-$3M$959K$1M$7M
Accumulated OCI$0$10M$12M$17M$0
Total Stockholders Equity-$8M$7M$13M$18M$28M
Total Liabilities & Equity$113K$41M$40M$44M$48M
— Key Metrics —
Total Debt$6M$34M$28M$25M$20M
Net Debt$6M$34M$28M$25M$20M
Total Investments$0$33M$26M$25M$26M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms